Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease

Parkinson’s disease, the second most common neurodegenerative disease in the world, develops due to decreased dopamine levels in the basal ganglia. Levodopa, a dopamine precursor used in the treatment of Parkinson’s disease, can be used as a drug delivery system. This study presents an approach to t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ezgi Saylam, Yigit Akkaya, Elif Ilhan, Sumeyye Cesur, Ece Guler, Ali Sahin, Muhammmet Emin Cam, Nazmi Ekren, Faik Nuzhet Oktar, Oguzhan Gunduz, Denisa Ficai, Anton Ficai
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	levodopa Parkinson’s disease 3D-printed scaffold biomaterials tissue engineering drug delivery Technology T Engineering (General). Civil engineering (General) TA1-2040 Biology (General) QH301-705.5 Physics QC1-999 Chemistry QD1-999
Acceso en línea:	https://doaj.org/article/5a32de00877d4bf1bcf76f834ab8d9b3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease

Ejemplares similares